Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mahmud

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Bone Marrow Transplantation|September 19, 2006
Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantationS Chunduri, L C Dobogai, D Peace, et al.
Bone Marrow Transplantation|June 23, 2009
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimenR Beri, S Chunduri, K Sweiss, et al.
Leukemia|January 22, 1998
Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell originH Miwa, M Mizutani, N Mahmud, et al.
British Journal of Haematology|May 8, 1999
Possible involvement of bcl-2 in regulation of cell-cycle progression of haemopoietic cells by transforming growth factor-beta1N Mahmud, N Katayama, K Nishii, et al.
Human Gene Therapy|August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivoA Bartholomew, S Patil, A Mackay, et al.
British Journal of Cancer|March 20, 2003
Detection of replicative integrity in small colonic biopsies using the BrdUrd comet assayA P McGlynn, G R Wasson, S O'Reilly, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
Experimental Hematology|February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusionS M Devine, A M Bartholomew, N Mahmud, et al.
Human Genetics|April 6, 2011
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcriptZ Kote-Jarai, A Amin Al Olama, D Leongamornlert, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Bone Marrow Transplantation|September 19, 2006
Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantationS Chunduri, L C Dobogai, D Peace, et al.
Bone Marrow Transplantation|June 23, 2009
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimenR Beri, S Chunduri, K Sweiss, et al.
Leukemia|January 22, 1998
Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell originH Miwa, M Mizutani, N Mahmud, et al.
British Journal of Haematology|May 8, 1999
Possible involvement of bcl-2 in regulation of cell-cycle progression of haemopoietic cells by transforming growth factor-beta1N Mahmud, N Katayama, K Nishii, et al.
Human Gene Therapy|August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivoA Bartholomew, S Patil, A Mackay, et al.
British Journal of Cancer|March 20, 2003
Detection of replicative integrity in small colonic biopsies using the BrdUrd comet assayA P McGlynn, G R Wasson, S O'Reilly, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
Experimental Hematology|February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusionS M Devine, A M Bartholomew, N Mahmud, et al.
Human Genetics|April 6, 2011
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcriptZ Kote-Jarai, A Amin Al Olama, D Leongamornlert, et al.
Pageof 7